Prognosis of Lymphoma in Patients With Known Inflammatory Bowel Disease: A French Multicentre Cohort Study
T Severyns(Université Paris Cité), J.M. Gornet(Université Paris Cité), Catherine Thiéblemont(Université Paris Cité), Aurélien Amiot(Université Paris-Est Créteil), Thomas Aparicio(Université Paris Cité), Laurent Beaugerie(Assistance Publique – Hôpitaux de Paris), Paul Coppo(Sorbonne Université), Véred Abitbol(Hôpital Cochin), Jérôme Lambert(Délégation Paris 7), Xavier Tréton(Hôpital Beaujon), Bénédicte Deau(Hôpital Necker-Enfants Malades), Anouk Walter‐Petrich(Inserm), Dominique Cazals‐Hatem, Caroline Besson(Bicêtre Hospital), Georgia Malamut(Délégation Paris 5), Julien Kirchgesner(Université Paris-Est Créteil), Matthieu Allez(Inserm), Lionel Galicier(Hôpital de la Timone)
Cited by 10
Related Papers
Potential of fecal microbiota for early‐stage detection of colorectal cancer
|Molecular Systems Biology|2014|1.4k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777